News
PraxisUnico joins forces with partners to support emerging healthcare businesses
18 January 2012
Cambridge, UK, 18 January 2012 – PraxisUnico, the leading research commercialisation body, has joined forces with Stevenage Bioscience Catalyst (SBC) - the UK’s first open innovation bioscience campus – and the Technology Strategy Board to deliver a seminar and networking forum to give aspiring entrepreneurs and young healthcare businesses an insight into how to start-up, fund and grow innovative new companies.
PraxisUnico responds to Innovation and Research Strategy for Growth
9 December 2011
PraxisUnico responds to Department of Business Innovation and Skills, Innovation and Research Strategy for Growth
PraxisUnico: Congratulations on new roles for committee members
18 November 2011
PraxisUnico congratulates committee members.
PraxisUnico: Welcomes new committee members
4 November 2011
PraxisUnico warmly welcome new committee members to its Conference and Member Service Committees.
PraxisUnico: Spinouts UK Survey second Quarterly Journal
1 November 2011
The PraxisUnico Spinouts UK Survey second Quarterly Journal contains a mix of news, facts, figures, and analysis of interest.
MTI launches venture fund to support commercialisation at three UK universities
15 February 2012
Three of the UK’s leading universities have secured a major deal that will bring up to £150 million into commercialising new technology.
Isis Innovation: Isis start-up provides sentiment analysis tool for business, finance
13 February 2012
Oxford-developed software which builds on a deep understanding of linguistics to assess accurately what people mean from what they say online will provide a “sentiment analysis” tool for businesses, particularly finance companies.
London Metropolitan University: The Duke of York launches cracking student business programme
1 February 2012
London Metropolitan University’s successful business start-up programme was today officially opened by The Duke of York.
Isis Innovation: Oxford company raises £3m to commercialise predictive cancer biomarkers
24 January 2012
Treating only patients who are likely to benefit from anti-cancer drugs and identifying quickly which treatment is best for each person, is the aim behind a new spin-out from the University of Oxford, Oxford Cancer Biomarkers Limited (OCB).
Inteum Company - new Director of Business Development
12 January 2012
Inteum Company announces Ms. Hope Hartman as their new Director of Business Development.
Sector
PraxisUnico is an educational not-for-profit organisation set up to support innovation and commercialisation of public sector and charity research for social and economic impact.
PraxisUnico encourages innovation and acts as a voice for the research commercialisation profession, facilitating the interaction between the public sector research base, business and government. PraxisUnico provides a forum for best practice exchange, underpinned by first-class training and development programmes.
